Plasma Dihydroceramides Are Associated With Hepatic Steatosis in Type 1 and Type 2 Diabetes
NCT03447964
·
clinicaltrials.gov ↗
COMPLETED
Status
128
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 1
Interventions
OTHER:
dosing of sphingolipids
Sponsor
Groupe Hospitalier Pitie-Salpetriere